Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Healthy weight: The key to a healthy heart

A healthy weight is the key to a healthy heart, and yet an estimated 1 out of 3 children is either overweight or obese in the U.S. During a special symposium Oct. 27 at the American Academy of Pediatrics National Conference and Exhibition in Orlando, pediatricians discussed obesity and cardiovascular risk factors, public health policy, and how physicians can partner with families to improve children's weight.

28 Oct 2013

Researchers study genetic factors associated to metabolic syndrome

Researchers from the Institute of Genomic Medicine carried out a study on genetic factors that can be associated to metabolic syndrome, main trigger of cardiovascular diseases, type II diabetes and obesity, with the goal of identifying high risk populations and influence its treatment in the most effective way.

25 Oct 2013

Diabetic patients may require higher doses of metformin to achieve same anti-cancer activity

A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.

25 Oct 2013

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

The Endocrine Society today issued a Clinical Practice Guideline for the diagnosis and treatment of polycystic ovary syndrome, the most common hormone disorder in women of reproductive age and a leading cause of infertility.

25 Oct 2013

Researchers discover novel genetic cause of severe obesity

Researchers from the University of Cambridge have discovered a novel genetic cause of severe obesity which, although relatively rare, demonstrates for the first time that genes can reduce basal metabolic rate - how the body burns calories.

25 Oct 2013

Biolinerx Inks In-License Agreement With Israeli Institutions For Type 1 Diabetes Treatment

...

24 Oct 2013

Type 1 diabetes modifies communication between central nervous system and bone marrow

A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.

24 Oct 2013

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

The fact that sleep deprivation has an impact on the function of the human immune system is well known. In their latest study, the University of Helsinki research group Sleep Team has now discovered new biological links between sleep loss and the immune system. The results provide at least a partial explanation of why sleep deprivation increases the risk of cardiovascular disease and type 2 diabetes.

24 Oct 2013

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer.

24 Oct 2013

Biolinerx In-Licenses Type 1 Diabetes Treatment With Israel Institutions

...

23 Oct 2013

Study evaluates role of enteroviruses in human type 1 diabetes

Type 1 diabetes is a disease caused by the destruction of the insulin-producing cells in the pancreas. It is often diagnosed in childhood and requires life-long treatment with daily insulin injections. It is associated with an increased risk for long-term complications which decrease the quality of life and average life-expectancy.

23 Oct 2013

Clinical trial to investigate if vitamin D supplement helps prevent type 2 diabetes

Researchers have begun the first definitive, large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay type 2 diabetes in adults who have prediabetes, who are at high risk for developing type 2. Funded by the National Institutes of Health, the study is taking place at about 20 study sites across the United States.

23 Oct 2013

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

...

22 Oct 2013

New NPS MedicineWise case study focuses on type 2 diabetes

The latest NPS MedicineWise case study Type 2 diabetes: tailoring ongoing treatment has been launched in a new dynamic online format. The case study focuses on available treatment options for a 75-year-old male with type 2 diabetes and offers continuing professional development points for GPs, pharmacists and nurses.

22 Oct 2013

Clinical trial to determine whether vitamin D helps prevent or delay development of type 2 diabetes

UT Southwestern Medical Center researchers are seeking 150 to 200 adults to take part in the local arm of a major national clinical trial that will investigate whether vitamin D helps prevent or delay development of type 2 diabetes.

22 Oct 2013

Researchers receive NIH grant to conduct Vitamin D and Type 2 diabetes study

A research team led by Anastassios G. Pittas, MD, MS, Endocrinologist and Co-Director of the Diabetes Center at Tufts Medical Center in Boston, has received a National Institutes of Health grant of more than $40 million over five years to conduct the Vitamin D and Type 2 diabetes study.

22 Oct 2013

Binge drinking increases atherosclerotic progression, stroke mortality risk in men

A Finnish population-based study showed that binge drinking was associated with increased atherosclerotic progression in an 11-year follow-up of middle-aged men. The progression of atherosclerosis was increased among men who consumed 6 drinks or more on one occasion.

21 Oct 2013

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).

19 Oct 2013

Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

...

18 Oct 2013

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

DPP-4 inhibitors may reduce risk of autoimmune diseases

Healthy weight: The key to a healthy heart

Researchers study genetic factors associated to metabolic syndrome

Diabetic patients may require higher doses of metformin to achieve same anti-cancer activity

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

Researchers discover novel genetic cause of severe obesity

Biolinerx Inks In-License Agreement With Israeli Institutions For Type 1 Diabetes Treatment

Type 1 diabetes modifies communication between central nervous system and bone marrow

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Biolinerx In-Licenses Type 1 Diabetes Treatment With Israel Institutions

Study evaluates role of enteroviruses in human type 1 diabetes

Clinical trial to investigate if vitamin D supplement helps prevent type 2 diabetes

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

New NPS MedicineWise case study focuses on type 2 diabetes

Clinical trial to determine whether vitamin D helps prevent or delay development of type 2 diabetes

Researchers receive NIH grant to conduct Vitamin D and Type 2 diabetes study

Binge drinking increases atherosclerotic progression, stroke mortality risk in men

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in